Quantcast

Subscribe to:
POZ magazine
Newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr Instagram
POZ Personals
Sign In / Join
Username:
Password:
Welcome, Guest. Please login or register.
December 24, 2014, 10:45:38 PM

Login with username, password and session length


Members
  • Total Members: 24282
  • Latest: Cincy
Stats
  • Total Posts: 650342
  • Total Topics: 49649
  • Online Today: 259
  • Online Ever: 585
  • (January 07, 2014, 02:31:47 PM)
Users Online

Welcome


Welcome to the POZ/AIDSmeds Community Forums, a round-the-clock discussion area for people with HIV/AIDS, their friends/family/caregivers, and others concerned about HIV/AIDS.  Click on the links below to browse our various forums; scroll down for a glance at the most recent posts; or join in the conversation yourself by registering on the left side of this page.

Privacy Warning:  Please realize that these forums are open to all, and are fully searchable via Google and other search engines. If you are HIV positive and disclose this in our forums, then it is almost the same thing as telling the whole world (or at least the World Wide Web). If this concerns you, then do not use a username or avatar that are self-identifying in any way. We do not allow the deletion of anything you post in these forums, so think before you post.

  • The information shared in these forums, by moderators and members, is designed to complement, not replace, the relationship between an individual and his/her own physician.

  • All members of these forums are, by default, not considered to be licensed medical providers. If otherwise, users must clearly define themselves as such.

  • Forums members must behave at all times with respect and honesty. Posting guidelines, including time-out and banning policies, have been established by the moderators of these forums. Click here for “Am I Infected?” posting guidelines. Click here for posting guidelines pertaining to all other POZ/AIDSmeds community forums.

  • We ask all forums members to provide references for health/medical/scientific information they provide, when it is not a personal experience being discussed. Please provide hyperlinks with full URLs or full citations of published works not available via the Internet. Additionally, all forums members must post information which are true and correct to their knowledge.

  • Product advertisement—including links; banners; editorial content; and clinical trial, study or survey participation—is strictly prohibited by forums members unless permission has been secured from POZ.

To change forums navigation language settings, click here (members only), Register now

Para cambiar sus preferencias de los foros en español, haz clic aquí (sólo miembros), Regístrate ahora

Finished Reading This? You can collapse this or any other box on this page by clicking the symbol in each box.

Author Topic: The Year In HIV/Aids  (Read 805 times)

0 Members and 1 Guest are viewing this topic.

Offline J.R.E.

  • Member
  • Posts: 7,284
  • Joined Dec-2003 Living positive, since 1985.
The Year In HIV/Aids
« on: December 28, 2006, 08:45:50 AM »
The Year in HIV/AIDS

http://www.medpagetoday.com/InfectiousDisease/HIVAIDS/dh/4767

     
  By Michael Smith, Senior Staff Writer, MedPage Today
December 27, 2006
 
 
Additional HIV/AIDS Coverage 


TORONTO, Dec. 27 - Researchers and clinicians descended en masse on this city this year for the World AIDS Conference -- the first time in a decade the meeting has been held in North America.

"While there was the usual hoopla of demonstrations and political grandstanding, there was also a renewed emphasis on the science of the pandemic, with marathon sessions devoted to new research.


The following summary reviews some of the highlights of the year in HIV/AIDS. For fuller accounts, links to the individual articles published in MedPage Today have been provided.


IAC: HIV/AIDS Science Regains Center Stage

AIDS World Conference

Among the findings reported at the World AIDS Conference was one that was mildly disappointing in some circles - that adding more drugs to a standard three-drug regimen had no benefit. Adding another drug might have improved efficacy, some researchers had suggested, although the downside might be increased complexity, toxicity, and cost. But a three-year randomized trial scotched that idea.


IAC: Four HIV Drugs No Better Than Three

On the other hand, the conference was told, once the disease is well in hand, it may be possible to drop two of the three drugs and keep things under control with just one. In patients who had well-controlled HIV and no history of previous virologic failure, the switch was effective, safe, and well tolerated, a Brazilian researcher said.


IAC: Kaletra Alone Can Keep Suppressed HIV at Bay

The effect of HIV drugs on the heart has long been a concern, especially since many of the medications appear to increase what would normally be thought of as risk factors for cardiovascular disease. A Swedish investigator told the meeting that the cardiovascular effect is real, but small in comparison to the benefit patients get by taking HIV drugs.


IAC: HIV Therapy's Impact on Heart Disease Small but Bears Watching

Another concern has been the long-term effects of the drugs, especially in children. But based on a cohort study of 133 HIV-positive children long-term treatment of children with protease inhibitor-based therapy appears to be well-tolerated, without apparent developmental abnormalities, a Swiss researcher said.

IAC: Long-Term Therapy with Antiretrovirals Tolerated by Children

Circumcision

Late in the year, two major U.S.-funded trials in Africa were halted when data monitoring committees agreed the evidence was overwhelming that circumcision cuts the risk of heterosexual transmission of HIV by about 50%. A study of 2,784 HIV-negative men in Kenya found a 53% reduction in HIV acquisition in circumcised men, while a similar trial in 4,996 HIV-negative men in Uganda, showed a 48% reduction. Both trials were prospective and randomized but - for obvious reasons - blinded.

Circumcision Halves Risk of Heterosexual HIV Transmission

Single Pill

The improvement of highly active anti-retroviral therapy (HAART) may have hit a peak early in 2006, with the approval of Atripla - a single pill, taken once daily, containing 600 mg of Sustiva (efavirenz), 200 mg of Emtriva (emtricitabine), and 300 mg of Viread (tenofovir DF). The three are among the most commonly used anti-HIV medications and are generally regarded as among the most effective as a combination. The co-formulation required three drug companies to work together - one reason the approval was hailed as "an extraordinary achievement."


FDA Okays Atripla as Once-Daily Therapy for HIV

Mortality

Improvements such as Atripla -- in the number, type, and quality of medications used in HAART have resulted in lower viral loads and higher immune cell counts, according to an international group of researchers. Surprisingly, however, these gains have not translated into a decline in mortality or progression to AIDS. The initial introduction of HAART in the mid-1990s slashed the death rate dramatically, but since then it has remained relatively steady, the researchers said.


HAART's Improving Control of HIV Has Bottom-Line Limit

Two studies this year showed that the power of HAART is restricted to the blood stream, and has little effect on HIV infection in the gut, the home of a very large proportion of the body's immune cells. The findings suggest that even when HIV is undetectable in the blood, it's percolating away in the gut-associated lymphoid tissue (GALT), which accounts for about 70% of the immune system.

(HIV Lingers in Gut Despite HAART and
In HIV Infection, HAART Little Help to Gut Immune Cells)

Drug Holiday

The notion of on-again, off-again drug therapy for HIV was… well … on and off this year. Two studies suggested that so-called drug holidays were of no benefit and might actually harm patients, while a third study suggested that the idea might still have value and should be revisited.



Testing for All

Despite controversy, the CDC urged this year that HIV tests should be part of routine medical care for all Americans from the ages of 13 to 64, not just those thought to be at high risk for the disease. The goal is to reduce the number of Americans - thought to be about a quarter-million - who are HIV-positive and don't know it. But critics worried that the follow-up - counseling and treatment - would not be in place for another 250,000 patients.

CDC Urges HIV Tests as Routine in Health Care and
Proposed HIV Testing Guidelines Draw Fire

Index Chimps :

And finally we may know who to blame for HIV. Researchers from Cambridge University said they've traced what appears to be the earliest transmission of simian immunodeficiency virus to humans - by digging into piles of chimpanzee feces in Cameroon, in West Central Africa. The fecal mess yielded viral samples that closely match the HIV-1 taken from the first known victim of AIDS - implying that the blame lies with a troop of chimps living in the region in the late 1950s. "

Current Meds ; Viramune, Epzicom, 40mg of simvastatin, 25 mg of Hydrochlorothiazide.
Metoprolol tartrate 25mg



http://forums.poz.com/index.php?topic=40802.0

http://forums.poz.com/index.php?topic=45159.0

http://forums.poz.com/index.php?topic=39722.msg495621;topicseen#msg495621

http://forums.poz.com/index.php?topic=46806.0

http://forums.poz.com/index.php?topic=39414.msg491701#msg491701


Diagnosed positive in 1985,.. In October of 2003, My t-cell count was 16, Viral load was over 500,000, Percentage at that time was 5%. I started on  HAART on October 24th, 2003.

 As of 12/10/14,  t-cells are at 350,  Previous 8/25/14--- 402/ Viral load remains <40

 Current % is at 13% / Previous 8/25/14 11%

  
 63 years young.

Offline koi1

  • Member
  • Posts: 713
Re: The Year In HIV/Aids
« Reply #1 on: December 28, 2006, 10:36:02 AM »
I wonder how much credence there is in the once your condition is stable, then you can go on to just one drug?

That would be good new because of drug toxicity side effects, and adherence. However, the research strongly upholds the notion that you must have at least two classes of aidsmeds involved.

rob
diagnosed on 11/20/06 viral load 23,000  cd4 97    8%
01/04/07 six weeks after diagnosis vl 53,000 cd4 cd4 70    6%
Began sustiva truvada 01/04/07
newest labs  drawn on 01/15/07  vl 1,100    cd4 119    7%
Drawn 02/10/07
cd4=160 viral load= 131 percentage= 8%
New labs 3/10/07 (two months on sustiva truvada
cd4 count 292  percentage 14 viral load undetectable

Offline Eldon

  • Member
  • Posts: 2,664
Re: The Year In HIV/Aids
« Reply #2 on: December 29, 2006, 03:29:39 AM »
Yes, I AM Supporting You!

Hey Ray...

This is defintely broken down into their seperate areas. Thank you for taking your time out to share this with the group. It has been noted and will be followed as well.

Happy New Year for 2007!!! and BEST wishes to YOU!
 

Don't You Dare Give Up... Don't You Dare Give In...
BECAUSE It IS ALL Within YOU to WIN!!!

 


Terms of Membership for these forums
 

© 2014 Smart + Strong. All Rights Reserved.   terms of use and your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.